MRI reveals the in vivo cellular and vascular response to BEZ235 in ovarian cancer xenografts with different PI3-kinase pathway activity
Jana Cebulla(Norwegian University of Science and Technology), Siver Andreas Moestue(St Olav's University Hospital)
Cited by 31
Related Papers
Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer
|Breast Cancer Research|2013|47